Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.04 per share
-
Shares outstanding
-
106,324,269
-
Total 13F shares
-
21,135,686
-
Share change
-
-1,181,407
-
Total reported value
-
$34,237,327
-
Put/Call ratio
-
10%
-
Price per share
-
$1.62
-
Number of holders
-
50
-
Value change
-
-$2,165,096
-
Number of buys
-
19
-
Number of sells
-
20
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) as of Q2 2023
As of 30 Jun 2023,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,135,686 shares.
The largest 10 holders included
Privium Fund Management B.V., ADAGE CAPITAL PARTNERS GP, L.L.C., EcoR1 Capital, LLC, M28 Capital Management LP, DAFNA Capital Management LLC, Opaleye Management Inc., MACQUARIE GROUP LTD, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, and TWO SIGMA INVESTMENTS, LP.
This page lists
50
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.